These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis. Uzawa A; Suzuki S; Kuwabara S; Akamine H; Onishi Y; Yasuda M; Ozawa Y; Kawaguchi N; Kubota T; Takahashi MP; Suzuki Y; Watanabe G; Kimura T; Sugimoto T; Samukawa M; Minami N; Masuda M; Konno S; Nagane Y; Utsugisawa K J Neurol Neurosurg Psychiatry; 2023 Jun; 94(6):467-473. PubMed ID: 36693723 [TBL] [Abstract][Full Text] [Related]
3. Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan. Imai T; Utsugisawa K; Murai H; Tsuda E; Nagane Y; Suzuki Y; Minami N; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Akaishi T; Aoki M J Neurol Neurosurg Psychiatry; 2018 May; 89(5):513-517. PubMed ID: 29175893 [TBL] [Abstract][Full Text] [Related]
4. Rationale for the clinical guidelines for myasthenia gravis in Japan. Murai H; Utsugisawa K; Nagane Y; Suzuki S; Imai T; Motomura M Ann N Y Acad Sci; 2018 Feb; 1413(1):35-40. PubMed ID: 29377151 [TBL] [Abstract][Full Text] [Related]
5. Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis. Uzawa A; Suzuki S; Kuwabara S; Akamine H; Onishi Y; Yasuda M; Ozawa Y; Kawaguchi N; Kubota T; Takahashi MP; Suzuki Y; Watanabe G; Kimura T; Sugimoto T; Samukawa M; Minami N; Masuda M; Konno S; Nagane Y; Utsugisawa K Neurotherapeutics; 2023 Mar; 20(2):518-523. PubMed ID: 36607596 [TBL] [Abstract][Full Text] [Related]
6. Oral corticosteroid therapy and present disease status in myasthenia gravis. Imai T; Suzuki S; Tsuda E; Nagane Y; Murai H; Masuda M; Konno S; Suzuki Y; Nakane S; Fujihara K; Suzuki N; Utsugisawa K Muscle Nerve; 2015 May; 51(5):692-6. PubMed ID: 25155615 [TBL] [Abstract][Full Text] [Related]
16. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study. Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724 [TBL] [Abstract][Full Text] [Related]
18. Decompensating esophoria as the presenting feature of myasthenia gravis. Arblaster GE; Shipman TL; Pepper IM J AAPOS; 2009 Jun; 13(3):310-1. PubMed ID: 19395293 [TBL] [Abstract][Full Text] [Related]
19. Rituximab for myasthenia gravis: three case reports and review of the literature. Stieglbauer K; Topakian R; Schäffer V; Aichner FT J Neurol Sci; 2009 May; 280(1-2):120-2. PubMed ID: 19272616 [TBL] [Abstract][Full Text] [Related]